You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1175 YH006, a fully human Treg-depleting CTLA-4×OX40 bispecific antibody, demonstrates superior preclinical efficacy and favorable developability

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immuno-Conjugates and Chimeric Molecules
1175 YH006, a fully human Treg-depleting CTLA-4×OX40 bispecific antibody, demonstrates superior preclinical efficacy and favorable developability

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023160014
Dec 202384012
Jan 20243508
Feb 20243204
Mar 20245807
Apr 20242402
May 20242002
Jun 20242601
Jul 20242601
Aug 20243803
Sep 20242202
Oct 20242605
Nov 20241304
Dec 20243408
Jan 20253605
Feb 2025603
Mar 2025002
Apr 2025008
May 20250010
Jun 2025002
Total6400103